Kjarninn - 22.08.2013, Page 112

Kjarninn - 22.08.2013, Page 112
“Not only are we averse to stressors, and don´t understand them, but we are committing crimes against life, the living, science, and wisdom, for the sake of eliminating volatility and variation. I feel anger and frustration when I thingk that one in ten Americans beyond the age of high school is on some kind of antidepressant, such as Prozac. Indeed, when you go through mood swings, you now have to justify why you are not on some medication. There may be a few good reasons to be on medications, in severely pathological cases, but my mood, my sadness, my bouts of anxiety, are a second source of intelligence­perhaps even the first source. I get mellow and lose physical energy when it rains, become more meditative, and tend to write more and more slowly then, with the raindrops hitting the window, what Verlaine called autumnal “sobs” Some days I enter poetic melancholic states, what the Portuguese call saudade or the Turks hüzün (from the Arabic word for sadness). Other days I am more aggressive, have more energy­and will write less, walk more, do other things, argue with researchers, answer emails, draw graphs on blackboards. Should I have turned into vegetable or a happy impecile? Had Prozac been available last century, Baudelaire's “spleen,” Edgar Allan Poe´s moods, the poetry of Sylvia Plath, the lamentations of so many other poets, everything wit a soul would have been silenced... If large pharmaceutical companies were able to eliminate the seasons, they would probably do so – for profit, of course. There is another danger: in additions to harming children, we are harming society and our future. Measures that aim at reducing variability and swings in the lives of children are also reducing variability and differences within our said to be Great Culturally Globalized Society. (Úr kaflanum Crimes against children, bls 61.) brot úr bóKinni Taleb hefur miklar áhyggjur af því að samfélagið vinni statt og stöðugt gegn óvissu og óreiðu og bæli niður eðlilegar skapsveiflur í boði lyfjafyrirtækjanna. 5/05 kjarninn ExIT
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Page 63
Page 64
Page 65
Page 66
Page 67
Page 68
Page 69
Page 70
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Page 77
Page 78
Page 79
Page 80
Page 81
Page 82
Page 83
Page 84
Page 85
Page 86
Page 87
Page 88
Page 89
Page 90
Page 91
Page 92
Page 93
Page 94
Page 95
Page 96
Page 97
Page 98
Page 99
Page 100
Page 101
Page 102
Page 103
Page 104
Page 105
Page 106
Page 107
Page 108
Page 109
Page 110
Page 111
Page 112
Page 113
Page 114
Page 115
Page 116
Page 117
Page 118
Page 119
Page 120
Page 121
Page 122
Page 123
Page 124
Page 125
Page 126
Page 127

x

Kjarninn

Direct Links

If you want to link to this newspaper/magazine, please use these links:

Link to this newspaper/magazine: Kjarninn
https://timarit.is/publication/958

Link to this issue:

Link to this page:

Link to this article:

Please do not link directly to images or PDFs on Timarit.is as such URLs may change without warning. Please use the URLs provided above for linking to the website.